Natria T, Watanabe R, Kitagawa T
Gan. 1980 Dec;71(6):755-8.
The mechanisms of inhibition by simultaneously administered phenobarbital of 3'-methyl-4-(dimethylamino)azobenzene (3'-Me-DAB)-induced hepatocarcinogenesis in the rat were studied. Weanling rats were fed a diet containing 0.06% 3'-Me-DAB or 0.06% 3'-Me-DAB and 0.05% phenobarbital for 3 weeks, followed by either basal diet or a diet containing 0.05% phenobarbital as a promoter. The number and the size of enzyme-altered islands and the number of tumors larger than 5 mm in diameter were scored at week 12 and week 40, respectively. The simultaneous feeding of phenobarbital and 3'-Me-DAB resulted in a significant decrease in the number and size of enzyme-altered islands and in the number of tumors, in comparison with those scored in animals fed 3'-Me-DAB alone. It was concluded that the simultaneous feeding of phenobarbital inhibits both the initiation of carcinogenesis and also the promotive action of the carcinogen resulting from its selective toxicity on the liver tissue.
研究了同时给予苯巴比妥对大鼠3'-甲基-4-(二甲基氨基)偶氮苯(3'-Me-DAB)诱导肝癌发生的抑制机制。将断乳大鼠喂以含0.06% 3'-Me-DAB或含0.06% 3'-Me-DAB和0.05%苯巴比妥的饲料3周,随后给予基础饲料或含0.05%苯巴比妥作为促癌剂的饲料。分别在第12周和第40周对酶改变岛的数量和大小以及直径大于5mm的肿瘤数量进行评分。与单独喂3'-Me-DAB的动物相比,同时给予苯巴比妥和3'-Me-DAB可使酶改变岛的数量和大小以及肿瘤数量显著减少。得出的结论是,同时给予苯巴比妥可抑制致癌作用的起始以及致癌物因其对肝组织的选择性毒性而产生的促癌作用。